+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Europe Sepsis Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product, Technology, Method, Test Type, Pathogen, and End User

  • PDF Icon

    Report

  • 198 Pages
  • August 2022
  • Region: Europe
  • The Insight Partners
  • ID: 5647351
UP TO OFF until Mar 31st 2024
The Europe sepsis diagnostics market is expected to grow from US$ 193.12 million in 2021 to US$ 360.55 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.

Technology is a critical parameter in healthcare diagnostics to provide accuracy and save time and resources. In the sepsis diagnosis process, identifying the causative pathogen is essential in selecting appropriate antibiotic therapy as part of the treatment. Molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology are majorly used sepsis diagnostics techniques. Among all, molecular diagnostics (MDx) is an attractive approach to consider for sepsis diagnostics. The increasing adoption of molecular diagnostic technology due to its several advantages, such as high sensitivity, accuracy, and less turnaround time, over other technologies has proved it the gold standard. Therefore, several companies are investing in point-of-care molecular diagnostics to diagnose bacterial and viral pathogens early and for better patient management.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe sepsis diagnostics market. The Europe sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

Europe Sepsis Diagnostics Market Segmentation

The Europe sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the Europe sepsis diagnostics market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media dominated the Europe sepsis diagnostics market in 2021. Based on technology, the Europe sepsis diagnostics market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the Europe sepsis diagnostics market in 2021. Based on method, the Europe sepsis diagnostics market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the Europe sepsis diagnostics market in 2021. Based on test type, the Europe sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the Europe sepsis diagnostics market in 2021. Based on pathogen, the Europe sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the Europe sepsis diagnostics market in 2021. Based on end user, the Europe sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the Europe sepsis diagnostics market in 2021. Based on country, the Europe sepsis diagnostics market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe sepsis diagnostics market in 2021.

Key players operating in the Europe sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; T2 Biosystems, Inc.; and Axis-Shield Diagnostics Ltd by Altair.
Frequently Asked Questions about the Middle Eastern and African Level Gauge Market

What is the estimated value of the Middle Eastern and African Level Gauge Market?

The Middle Eastern and African Level Gauge Market was estimated to be valued at $193.12 Million in 2022.

What is the growth rate of the Middle Eastern and African Level Gauge Market?

The growth rate of the Middle Eastern and African Level Gauge Market is 9.3%, with an estimated value of $360.55 Million by 2028.

What is the forecasted size of the Middle Eastern and African Level Gauge Market?

The Middle Eastern and African Level Gauge Market is estimated to be worth $360.55 Million by 2028.

Who are the key companies in the Middle Eastern and African Level Gauge Market?

Key companies in the Middle Eastern and African Level Gauge Market include Abbott, F. HOFFMANN, LA ROCHE LTD., Immunexpress Inc., BD, Danaher (Beckman Coulter), Luminex Corporation, THERMO FISHER SCIENTIFIC INC., bioMerieux SA and T2 Biosystems, Inc.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Sepsis Diagnostics Market - By Product
1.3.2 Europe Sepsis Diagnostics Market - By Technology
1.3.3 Europe Sepsis Diagnostics Market - By Method
1.3.4 Europe Sepsis Diagnostics Market - By Test Type
1.3.5 Europe Sepsis Diagnostics Market - By Pathogen
1.3.6 Europe Sepsis Diagnostics Market - By End User
1.3.7 Europe Sepsis Diagnostics Market - By Country

2. Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Sepsis Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe PEST Analysis
4.3 Experts Opinion

5. Europe Sepsis Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Increase in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Absence of Skilled Professionals
5.3 Market Opportunities
5.3.1 Rise in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Growing Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis

6. Sepsis Diagnostics Market- Europe Analysis
6.1 Europe Sepsis Diagnostics Market Revenue Forecast and Analysis

7. Europe Sepsis Diagnostics Market - By Product
7.1 Overview
7.2 Europe Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8. Europe Sepsis Diagnostics Market - By Technology
8.1 Overview
8.2 Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Sepsis Diagnostics Market - By Method
9.1 Overview
9.2 Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Sepsis Diagnostics Market - By Test Type
10.1 Overview
10.2 Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11. Europe Sepsis Diagnostics Market - By Pathogen
11.1 Overview
11.2 Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12. Europe Sepsis Diagnostics Market - By End User
12.1 Overview
12.2 Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13. Europe Sepsis Diagnostics Market - By Country Analysis
13.1 Europe: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4 Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.4.1 Germany: Sepsis Diagnostics Market, by Molecular diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.5 Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.6 Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.7 Germany: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.8 Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4 France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.4.1 France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.5 France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.6 France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.7 France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.8 France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4 UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.4.1 UK: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.5 UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.6 UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.7 UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.8 UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.1 Overview
13.1.2.4.2 Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.3 Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4 Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.4.1 Italy: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.5 Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.6 Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.7 Italy: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.1.2.4.8 Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.1 Overview
13.1.2.5.2 Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.3 Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4 Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.4.1 Spain: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.5 Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.6 Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.7 Spain: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
13.1.2.5.8 Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.1 Overview
13.1.2.6.2 Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.3 Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4 Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.4.1 Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics- Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.5 Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.6 Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.7 Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
13.1.2.6.8 Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)

14. Sepsis Diagnostics Market-Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview

15. Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Axis-Shield Diagnostics Ltd
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms

List of Figures
Figure 1. Europe Sepsis Diagnostics Market Segmentation
Figure 2. Europe Sepsis Diagnostics Market, By Country
Figure 3. Europe Sepsis Diagnostics Market Overview
Figure 4. Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Europe Experts Opinion
Figure 8. Europe Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Sepsis Diagnostics Market- Revenue Forecast and Analysis - 2021- 2028
Figure 10. Europe Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11. Europe Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Europe Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Europe Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Europe Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Europe Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)
Figure 16. Europe Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Europe Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Europe Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. Europe Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. Europe Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. Europe Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22. Europe Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23. Europe Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24. Europe Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25. Europe Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26. Europe Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)
Figure 27. Europe Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28. Europe Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29. Europe Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)
Figure 30. Europe Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Europe Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Europe Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)
Figure 33. Europe Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Europe Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36. Europe Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)
Figure 37. Europe Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Europe Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Europe Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Europe: Sepsis Diagnostics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 41. Europe: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42. Germany: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. France: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. UK: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Italy: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Spain: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Sepsis Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Growth Strategies in the Sepsis Diagnostics Market (%)List of Tables
Table 1. Germany: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Sepsis Diagnostics Market, by Molecular diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 11. France: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 12. France: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. France: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. UK: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. UK: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 18. UK: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 19. UK: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 20. UK: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 22. Italy: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 23. Italy: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 24. Italy: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 25. Italy: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Sepsis Diagnostics Market, by Pathogen- Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 31. Spain: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 32. Spain: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 35. Spain: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Europe: Sepsis Diagnostics Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 37. Rest of Europe: Sepsis Diagnostics Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 38. Rest of Europe: Sepsis Diagnostics Market, by Molecular Diagnostics - Revenue and Forecast to 2028 (US$ Million)
Table 39. Rest of Europe: Sepsis Diagnostics Market, by Method - Revenue and Forecast to 2028 (US$ Million)
Table 40. Rest of Europe: Sepsis Diagnostics Market, by Test Type - Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Sepsis Diagnostics Market, by Pathogen - Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Sepsis Diagnostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 43. Organic Developments in the Sepsis Diagnostics Market
Table 44. Inorganic Developments in the Sepsis Diagnostics Market
Table 45. Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • F. HOFFMANN-LA ROCHE LTD.
  • Immunexpress Inc.
  • BD
  • Danaher (Beckman Coulter)
  • Luminex Corporation
  • THERMO FISHER SCIENTIFIC INC.
  • bioMerieux SA
  • T2 Biosystems, Inc
  • Axis-Shield Diagnostics Ltd